Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

A research team investigates how genome editing can be harnessed to accelerate cassava breeding and improve key traits.

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

Now, Johns Hopkins Medicine scientists say they have shed new light on how bacteria protect themselves from certain phage ...

The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...

In this article, we are going to look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other biotech stocks. Biotech Sector Set for Growth Amid Innovation and Investor Interest The ...

After hours: March 21 at 7:54:03 p.m. EDT Loading Chart for CRSP ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...